Tezepelumab Phase 1 PK Study in Healthy Chinese Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Durvalumab(MEDI4736) and AZD6738 Combination Therapy in Relapsed Small Cell Lung Cancer Subjects
- Status
- COMPLETED
- Phase
- PHASE2
Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Cancer Patients
- Status
- COMPLETED
- Phase
- NA
A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Thoracic Radiotherapy Plus Durvalumab in Elderly and/or Frail NSCLC Stage III Patients Unfit for Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Dapagliflozin in Respiratory Failure in Patients With COVID-19
- Status
- COMPLETED
- Phase
- PHASE3
Maintenance With Olaparib or Selumetinib + Durvaluma for m-PDAC Guided by BRCAness and KRAS Status.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.
- Status
- COMPLETED
- Phase
- PHASE2
Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load
- Status
- TERMINATED
- Phase
- PHASE2
Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line Rechallenge
- Status
- RECRUITING
- Phase
- PHASE2
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE3
Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Study of Verinurad in Heart Failure With Preserved Ejection Fraction
- Status
- COMPLETED
- Phase
- PHASE2
Saracatinib Trial TO Prevent FOP
- Status
- RECRUITING
- Phase
- PHASE2
Monalizumab and Trastuzumab In Metastatic HER2-pOSitive breAst Cancer: MIMOSA-trial
- Status
- COMPLETED
- Phase
- PHASE2
Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma
- Status
- COMPLETED
- Phase
- PHASE3
Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Dapagliflozin in Acute Heart Failure
- Status
- COMPLETED
- Phase
- PHASE3
Durvalumab for Advanced Hepatocellular Carcinoma in Patients With Active Chronic Hepatitis B Virus Infection
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2